Immunity and AAV-Mediated Gene Therapy for Muscular Dystrophies in Large Animal Models and Human Trials

Adeno-associated viral (AAV) vector-mediated gene replacement for the treatment of muscular dystrophy represents a promising therapeutic strategy in modern medicine. One major obstacle in using AAV vectors for in vivo gene delivery is the development of host immune responses to the viral capsid prot...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zejing, Tapscott, Stephen J., Chamberlain, Jeffrey S., Storb, Rainer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Research Foundation 2011
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180173/
https://www.ncbi.nlm.nih.gov/pubmed/21980317
http://dx.doi.org/10.3389/fmicb.2011.00201

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180173/
https://www.ncbi.nlm.nih.gov/pubmed/21980317
http://dx.doi.org/10.3389/fmicb.2011.00201

Ejemplares similares